These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16821163)

  • 1. Drug evaluation: The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia.
    Burnett JR
    IDrugs; 2006 Jul; 9(7):495-9. PubMed ID: 16821163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JTT-705. Japan Tobacco.
    Linders JT
    Curr Opin Investig Drugs; 2004 Mar; 5(3):339-43. PubMed ID: 15083602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models.
    Mera Y; Kawai T; Ogawa N; Odani N; Sasase T; Miyajima K; Ohta T; Kakutani M
    J Pharmacol Sci; 2015 Nov; 129(3):169-76. PubMed ID: 26598005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia.
    Burnett JR
    Curr Opin Investig Drugs; 2006 Sep; 7(9):850-6. PubMed ID: 17002264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-8921 (Shionogi).
    Booker ML
    Curr Opin Investig Drugs; 2001 Mar; 2(3):393-5. PubMed ID: 11575711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal triglyceride transfer protein inhibition-friend or foe?
    Joy TR; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):506-8. PubMed ID: 18506153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hyperlipidemia with a new drug, tibric acid].
    Carmena R; González R Florez J; Sanchis J
    Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights into the novel hydrolytic mechanism of a diethyl 2-phenyl-2-(2-arylacetoxy)methyl malonate ester-based microsomal triglyceride transfer protein (MTP) inhibitor.
    Ryder T; Walker GS; Goosen TC; Ruggeri RB; Conn EL; Rocke BN; Lapham K; Steppan CM; Hepworth D; Kalgutkar AS
    Chem Res Toxicol; 2012 Oct; 25(10):2138-52. PubMed ID: 22989032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of hyperlipidemia and its treatment].
    Ouellet A
    Union Med Can; 1991; 120(3):238-43. PubMed ID: 1866844
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.
    Robinson RP; Bartlett JA; Bertinato P; Bessire AJ; Cosgrove J; Foley PM; Manion TB; Minich ML; Ramos B; Reese MR; Schmahai TJ; Swick AG; Tess DA; Vaz A; Wolford A
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4150-4. PubMed ID: 21684740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FM-VP4 Forbes Medi-Tech.
    Burnett JR
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1120-5. PubMed ID: 14582458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dibenzodioxocinones--a new class of CETP inhibitors.
    Brückner D; Hafner FT; Li V; Schmeck C; Telser J; Vakalopoulos A; Wirtz G
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3611-4. PubMed ID: 15975789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for hyperlipidemia.
    Am Pharm; 1988 Mar; NS28(3):91-5. PubMed ID: 3285656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microsomal triglyceride transfer protein inhibitor].
    Sugimoto T; Yamashita S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():665-70. PubMed ID: 11347150
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospects for the development of novel anti-hyperlipidemic drugs.
    Derosa G; Salvadeo S; Cicero AF
    Curr Opin Investig Drugs; 2006 Sep; 7(9):826-33. PubMed ID: 17002261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microsomal triglyceride transfer protein (MTP)].
    Yamashita S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():226-35. PubMed ID: 11351580
    [No Abstract]   [Full Text] [Related]  

  • 17. Bis[3-(4'-substituted phenyl)prop-2-ene]disulfides as a new class of antihyperlipidemic compounds.
    Sharma M; Tiwari M; Chandra R
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5347-50. PubMed ID: 15454225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of non-heparin glycosaminoglycans of natural origin.
    Bianchini P
    Semin Thromb Hemost; 1989 Oct; 15(4):365-9. PubMed ID: 2683090
    [No Abstract]   [Full Text] [Related]  

  • 19. Avasimibe Pfizer.
    Burnett JR; Huff MW
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1328-33. PubMed ID: 12498009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits.
    Xing WW; Wu JZ; Jia M; Du J; Zhang H; Qin LP
    Biomed Pharmacother; 2009 Aug; 63(7):457-62. PubMed ID: 18657948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.